Two years into the pandemic, unequal access to COVID-19 treatments threatens the global recovery
By Deborah Gleeson, Associate Professor in Public Health, La Trobe University
Brigitte Tenni, Senior Technical Advisor - HIV, The Nossal Institute for Global Health, PhD candidate La Trobe University, The University of Melbourne
Just as access to vaccines was vastly more difficult for low-income countries, the same is now true for the virus’ treatments: at potentially great cost to the world.
Read complete article
© The Conversation
-
Sunday, March 13, 2022